Skip to main content

Advertisement

Log in

Methods for a multicenter randomized trial for mixed urinary incontinence: rationale and patient-centeredness of the ESTEEM trial

  • Special Contribution
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Mixed urinary incontinence (MUI) can be a challenging condition to manage. We describe the protocol design and rationale for the Effects of Surgical Treatment Enhanced with Exercise for Mixed Urinary Incontinence (ESTEEM) trial, designed to compare a combined conservative and surgical treatment approach versus surgery alone for improving patient-centered MUI outcomes at 12 months.

Methods

ESTEEM is a multisite, prospective, randomized trial of female participants with MUI randomized to a standardized perioperative behavioral/pelvic floor exercise intervention plus midurethral sling versus midurethral sling alone. We describe our methods and four challenges encountered during the design phase: defining the study population, selecting relevant patient-centered outcomes, determining sample size estimates using a patient-reported outcome measure, and designing an analysis plan that accommodates MUI failure rates. A central theme in the design was patient centeredness, which guided many key decisions. Our primary outcome is patient-reported MUI symptoms measured using the Urogenital Distress Inventory (UDI) score at 12 months. Secondary outcomes include quality of life, sexual function, cost-effectiveness, time to failure, and need for additional treatment.

Results

The final study design was implemented in November 2013 across eight clinical sites in the Pelvic Floor Disorders Network. As of 27 February 2016, 433 total/472 targeted participants had been randomized.

Conclusions

We describe the ESTEEM protocol and our methods for reaching consensus for methodological challenges in designing a trial for MUI by maintaining the patient perspective at the core of key decisions. This trial will provide information that can directly impact patient care and clinical decision making.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Dooley Y, Kenton K, Cao G et al (2008) Urinary incontinence prevalence: results from the National Health and Nutrition Examination Survey. J Urol 179:656–61

    Article  PubMed  Google Scholar 

  2. Melville JL, Katon W, Delaney K, Newton K (2005) Urinary incontinence in US women: a population-based study. Arch Intern Med 165:537–42

    Article  PubMed  Google Scholar 

  3. Nygaard I, Barber MD, Burgio KL et al (2008) Prevalence of symptomatic pelvic floor disorders in US women. JAMA 300:1311–6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Sung VW, Raker CA, Myers DL, Clark MA (2009) Ambulatory care related to female pelvic floor disorders in the United States, 1995-2006. Am J Obstet Gynecol 201:508 e1–6

    Article  PubMed  Google Scholar 

  5. Wu JM, Kawasaki A, Hundley AF, Dieter AA, Myers ER, Sung VW (2011) Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. Am J Obstet Gynecol 205:230 e1–5

    Article  PubMed  Google Scholar 

  6. Wu JM, Hundley AF, Fulton RG, Myers ER (2009) Forecasting the prevalence of pelvic floor disorders in U.S. Women: 2010 to 2050. Obstet Gynecol 114:1278–83

    Article  PubMed  Google Scholar 

  7. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I (2008) The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int 101:1388–95

    Article  PubMed  Google Scholar 

  8. Rogers RG, Kammerer-Doak D, Villarreal A, Coates K, Qualls C (2001) A new instrument to measure sexual function in women with urinary incontinence or pelvic organ prolapse. Am J Obstet Gynecol 184:552–8

    Article  CAS  PubMed  Google Scholar 

  9. Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 3:291–306

    Article  CAS  PubMed  Google Scholar 

  10. Coyne KS, Wein AJ, Tubaro A et al (2009) The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTS. BJU Int 103(Suppl 3):4–11

    Article  PubMed  Google Scholar 

  11. Sung VW, Marques F, Rogers RR, Williams DA, Myers DL, Clark MA (2011) Content validation of the patient-reported outcomes measurement information system (PROMIS) framework in women with urinary incontinence. Neurourol Urodyn 30:503–9

    Article  PubMed  PubMed Central  Google Scholar 

  12. Haylen BT, de Ridder D, Freeman RM et al (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26

    Article  PubMed  Google Scholar 

  13. Kammerer-Doak D, Rizk DE, Sorinola O, Agur W, Ismail S, Bazi T (2014) Mixed urinary incontinence: international urogynecological association research and development committee opinion. Int Urogynecol J 25:1303–12

    Article  PubMed  Google Scholar 

  14. Karram MM, Bhatia NN (1989) Management of coexistent stress and urge urinary incontinence. Obstet Gynecol 73:4–7

    CAS  PubMed  Google Scholar 

  15. Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–36

    CAS  PubMed  Google Scholar 

  16. Monz B, Chartier-Kastler E, Hampel C et al (2007) Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE. Eur Urol 51:1073–81, discussion 81-2

    Article  PubMed  Google Scholar 

  17. Dooley Y, Lowenstein L, Kenton K, FitzGerald M, Brubaker L (2008) Mixed incontinence is more bothersome than pure incontinence subtypes. Int Urogynecol J Pelvic Floor Dysfunct 19:1359–62

    Article  PubMed  Google Scholar 

  18. Subak LL, Brubaker L, Chai TC et al (2008) High costs of urinary incontinence among women electing surgery to treat stress incontinence. Obstet Gynecol 111:899–907

    Article  PubMed  PubMed Central  Google Scholar 

  19. Brubaker L, Stoddard A, Richter H et al (2009) Mixed incontinence: comparing definitions in women having stress incontinence surgery. Neurourol Urodyn 28:268–73

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dmochowski R, Staskin D (2005) Mixed incontinence: definitions, outcomes, and interventions. Curr Opin Urol 15:374–9

    Article  PubMed  Google Scholar 

  21. Myers DL (2014) Female mixed urinary incontinence: a clinical review. JAMA 311:2007–14

    Article  CAS  PubMed  Google Scholar 

  22. Katsumi HK, Rutman MP (2010) Can we predict if overactive bladder symptoms will resolve after sling surgery in women with mixed urinary incontinence? Curr Urol Rep 11:328–37

    Article  PubMed  Google Scholar 

  23. Ulmsten U, Falconer C, Johnson P et al (1998) A multicenter study of tension-free vaginal tape (TVT) for surgical treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 9:210–3

    Article  CAS  PubMed  Google Scholar 

  24. Jain P, Jirschele K, Botros SM, Latthe PM Effectiveness of midurethral slings in mixed urinary incontinence: a systematic review and meta-analysis. Int Urogynecol J;22:923-32

  25. Richter HE, Albo ME, Zyczynski HM et al (2010) Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 362:2066–76

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Barber MD, Kleeman S, Karram MM et al (2008) Risk factors associated with failure 1 year after retropubic or transobturator midurethral slings. Am J Obstet Gynecol 199:666 e1–7

    Article  PubMed  Google Scholar 

  27. Barber MD, Kleeman S, Karram MM et al (2008) Transobturator tape compared with tension-free vaginal tape for the treatment of stress urinary incontinence: a randomized controlled trial. Obstet Gynecol 111:611–21

    Article  PubMed  Google Scholar 

  28. Palva K, Nilsson CG (2011) Prevalence of urinary urgency symptoms decreases by mid-urethral sling procedures for treatment of stress incontinence. Int Urogynecol J 22:1241–7

    Article  PubMed  Google Scholar 

  29. Brubaker L, Moalli P, Richter HE et al (2009) Challenges in designing a pragmatic clinical trial: the mixed incontinence -- medical or surgical approach (MIMOSA) trial experience. Clin Trials 6:355–64

    Article  PubMed  PubMed Central  Google Scholar 

  30. Brubaker L, Lukacz ES, Burgio K et al (2011) Mixed incontinence: comparing definitions in non-surgical patients. Neurourol Urodyn 30:47–51

    Article  PubMed  PubMed Central  Google Scholar 

  31. Swift SE, Yoon EA (1999) Test-retest reliability of the cough stress test in the evaluation of urinary incontinence. Obstet Gynecol 94:99–102

    CAS  PubMed  Google Scholar 

  32. Bosch JL, Cardozo L, Hashim H, Hilton P, Oelke M, Robinson D (2011) Constructing trials to show whether urodynamic studies are necessary in lower urinary tract dysfunction. Neurourol Urodyn 30:735–40

    Article  PubMed  Google Scholar 

  33. Nager CW, Brubaker L, Daneshgari F et al (2009) Design of the Value of Urodynamic Evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations. Contemp Clin Trials 30:531–9

    Article  PubMed  PubMed Central  Google Scholar 

  34. Nager CW, Kraus SR, Kenton K et al (2010) Urodynamics, the supine empty bladder stress test, and incontinence severity. Neurourol Urodyn 29:1306–11

    Article  PubMed  Google Scholar 

  35. Nager CW, Brubaker L, Litman HJ et al (2012) A randomized trial of urodynamic testing before stress-incontinence surgery. N Engl J Med 366:1987–97

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Hashim H, Abrams P (2006) Is the bladder a reliable witness for predicting detrusor overactivity? J Urol 175:191–4, discussion 94-5

    Article  CAS  PubMed  Google Scholar 

  37. Rovner ES, Goudelocke CM (2010) Urodynamics in the evaluation of overactive bladder. Curr Urol Rep 11:343–7

    Article  PubMed  Google Scholar 

  38. Burgio KL, Goode PS, Locher JL et al (2003) Predictors of outcome in the behavioral treatment of urinary incontinence in women. Obstet Gynecol 102:940–7

    PubMed  Google Scholar 

  39. Dumoulin C, Hay-Smith J. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2014:CD005654.

  40. Burgio KL (2013) Update on behavioral and physical therapies for incontinence and overactive bladder: the role of pelvic floor muscle training. Curr Urol Rep 14:457–64

    Article  PubMed  Google Scholar 

  41. Miller JM, Sampselle C, Ashton-Miller J, Hong GR, DeLancey JO (2008) Clarification and confirmation of the Knack maneuver: the effect of volitional pelvic floor muscle contraction to preempt expected stress incontinence. Int Urogynecol J Pelvic Floor Dysfunct 19:773–82

    Article  PubMed  PubMed Central  Google Scholar 

  42. Richter HE, Burgio KL, Brubaker L et al (2010) Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 115:609–17

    Article  PubMed  PubMed Central  Google Scholar 

  43. Burgio KL, Goode PS, Locher JL et al (2002) Behavioral training with and without biofeedback in the treatment of urge incontinence in older women: a randomized controlled trial. JAMA 288:2293–9

    Article  PubMed  Google Scholar 

  44. Burgio KL, Kraus SR, Menefee S et al (2008) Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med 149:161–9

    Article  PubMed  PubMed Central  Google Scholar 

  45. Barber MD, Brubaker L, Burgio KL et al (2014) Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA 311:1023–34

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Husby VS, Helgerud J, Bjorgen S, Husby OS, Benum P, Hoff J (2010) Early postoperative maximal strength training improves work efficiency 6-12 months after osteoarthritis-induced total hip arthroplasty in patients younger than 60 years. Am J Phys Med Rehabil 89:304–14

    Article  PubMed  Google Scholar 

  47. Patel MI, Yao J, Hirschhorn AD, Mungovan SF (2013) Preoperative pelvic floor physiotherapy improves continence after radical retropubic prostatectomy. Int J Urol: Off J Japanese Urol Assoc 20:986–92

    Google Scholar 

  48. Tienforti D, Sacco E, Marangi F et al (2012) Efficacy of an assisted low-intensity programme of perioperative pelvic floor muscle training in improving the recovery of continence after radical prostatectomy: a randomized controlled trial. BJU Int 110:1004–10

    Article  PubMed  Google Scholar 

  49. Borello-France D, Burgio KL, Goode PS et al (2013) Adherence to behavioral interventions for urge incontinence when combined with drug therapy: adherence rates, barriers, and predictors. Phys Ther 90:1493–505

    Article  Google Scholar 

  50. Abrams P, Andersson KE, Birder L et al (2010) Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 29:213–40

    Article  CAS  PubMed  Google Scholar 

  51. Staskin D, Tubaro A, Norton PA, Ashton-Miller JA (2011) Mechanisms of continence and surgical cure in female and male SUI: surgical research initiatives. Neurourol Urodyn 30:704–7

    Article  PubMed  Google Scholar 

  52. Guidance for Industry Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed June 1, 2015.

  53. Dyer KY, Xu Y, Brubaker L, et al. Minimum important difference for validated instruments in women with urge incontinence. Neurourol Urodyn;30:1319-24.

  54. Barber MD, Spino C, Janz NK et al (2009) The minimum important differences for the urinary scales of the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire. Am J Obstet Gynecol 200:580 e1–7

    Article  PubMed  Google Scholar 

  55. Lowenstein L, Kenton K, FitzGerald MP, Brubaker L (2008) Clinically useful measures in women with mixed urinary incontinence. Am J Obstet Gynecol 198:664 e1–3, discussion 64 e3-4

    Article  Google Scholar 

  56. Yalcin I, Bump RC (2003) Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol 189:98–101

    Article  PubMed  Google Scholar 

  57. Halme AS, Fritel X, Benedetti A, Eng K, Tannenbaum C (2015) Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes: A Comparison of Sample Size Requirements for an Incontinence Treatment Trial. Value Health 18:292–8

    Article  PubMed  Google Scholar 

  58. Brundage M, Blazeby J, Revicki D et al (2013) Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res 22:1161–75

    Article  PubMed  Google Scholar 

  59. Abdel-fattah M, Mostafa A, Young D, Ramsay I (2011) Evaluation of transobturator tension-free vaginal tapes in the management of women with mixed urinary incontinence: one-year outcomes. Am J Obstet Gynecol 205:150 e1–6

    Article  PubMed  Google Scholar 

  60. Calvert M, Blazeby J, Altman DG et al (2013) Reporting of patient-reported outcomes in randomized trials: the consort pro extension. JAMA 309:814–22

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge Alex Lynch for her technical expertise and Dr. Deborah Myers for her content expertise in the development and implementation phases of this study.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Vivian W. Sung.

Ethics declarations

Conflicts of interest

Vivian W. Sung - None

Diane Borello-France - None

Gena Dunivan

Pelvalon: Research funding

Marie Gantz - None

Emily S. Lukacz

Renew Medical, Inc: Research : 2010-2011; Consultant 2012-2015 for study of anal insert for accidental bowel leakage.

Pfizer: Study drug donated for trial on prevention of urinary tract infections.

AMS/Astora: Consultant: clinical events committee member for prolapse study, TOPAS sling for accidental bowel leakage.

Boston Scientific: Research funding for observational study of native tissue vaginal prolapse surgery

Uroplasty: Research funding for observational study of Macroplastique for intrinsic sphincter deficiency

Axonics: Consultant for development of neuromodulation technology

Grants: American Urogynecologic Society fellow research award: 2013 funding for study of prevention of urinary tract infection.

UpToDate – Royalties for chapters on urinary incontinence and perioperative management

NIH/NIDDK: Honoraria and travel for scientific consulting and Principal Investigator in the PLUS (Prevention of Lower Urinary Tract Symptoms) network

Pamela Moalli

ACell-Unrestricted Corporate Research Agreement

Diane K. Newman

Research support: VA, NIH, Wellspect

Holly Richter

Research Grants:

National Institute of Diabetes and Digestive and Kidney Diseases K24 Midcareer Award in Patient Oriented Pelvic Floor Research

Eunice Kennedy Shriver National Institute of Child Health and Human Development - Pelvic Floor Disorders Network

National Institute of Allergy & Infectious Diseases/National Institute of Health/Dept of Health and Human Services

Washington University/National Institutes of Health Pelvalon, Inc

Consultant: Kimberly Clarke, Astellas and Pelvalon, Inc

Royalties: UpToDate

Beri Ridgeway - None

Ariana L. Smith - None

Alison C. Weidner - None

Susan Meikle - None

Funding

Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10 HD041261, U10 HD069013, U10 HD054214, U10 HD054215, U10 HD041267, U10 HD069025, U10 HD069010, U10 HD069006, U01 HD069031) and the National Institutes of Health Office of Research on Women’s Health.

Additional information

Clinicaltrials.gov

NCT01959347

Appendix: Pelvic Floor Disorders Network contributors

Appendix: Pelvic Floor Disorders Network contributors

Cleveland Clinic

Mathew D. Barber, Principal Investigator

J. Eric Jelovsek, Co-Investigator

Marie Fidela R. Paraiso, Co-Investigator

Mark D. Walters, Co-Investigator

Beri Ridgeway, Co-Investigator

Brooke Gurland, Co-Investigator

Massarat Zutshi, Co-Investigator

Geetha Krishnan, Research Nurse Clinician

Ly Pung, Research Nurse

Annette Graham, Research Nurse Clinician

Alpert Medical School of Brown University-Women & Infant’s Hospital of Rhode island

Vivian W. Sung, Principal Investigator

Deborah L. Myers, Co-Investigator

Charles R. Rardin, Co-Investigator

Cassandra Carberry, Co-Investigator

B. Star Hampton, Co-Investigator

Kyle Wohlrab, Co-Investigator

Ann S. Meers, Research Nurse Coordinator

Duke University

Anthony Visco, Principal Investigator

Cindy Amundsen, Co-Investigator

Alison Weidner, Co-Investigator

Nazema Siddiqui, Co-Investigator

Ingrid Harm-Ernandes, Interventionist

Jennifer Maddocks, Interventionist

Shantae McLean, Research Coordinator

University of Alabama at Birmingham

Holly Richter, Primary Investigator

Alayne Markland, Co-Investigator

R. Edward Varner, Co-Investigator

Robert Holley, Co-Investigator

L. Keith Lloyd, Co-Investigator

Tracy S. Wilson, Co-Investigator

Alicia Ballard, Co-Investigator

Jeannine McCormick, Research Nurse Clinician

Velria Willis, Research Nurse Coordinator

Nancy Saxon, Research Nurse Coordinator

Kathy Carter, Research Nurse

Julie Burge, Research Coordinator

NIH Project Scientist

Susan Meikle, Primary Investigator

University of California, San Diego

Charles Nager, Principal Investigator

Michael Albo, Co-Investigator

Emily Lukacz, Co-Investigator

Cindy Furey, Interventionist

Patricia Riley, Interventionist

JoAnn Columbo, Research Coordinator

Sherella Johnson, Research Coordinator

Kaiser Permanente–San Diego

Shawn Menefee, Co-Investigator

Karl Luber, Co-Investigator

Keisha Dyer, Co-Investigator

Gouri Diwadkar, Co-Investigator

Jasmine Tan-Kim, Co-Investigator

University of New Mexico

Rebecca G. Rogers, Primary Investigator

Yuko Komesu, Co-Investigator

Gena Dunivan, Co-Investigator

Peter Jeppson, Co-Investigator

Sara Cichowski, Co-Investigator

Christy Miller, Interventionist

Barbara White, Interventionist

Sue Lee, Research Coordinator

Julia Middendorf, Research Nurse

RTI

Dennis Wallace, Primary Investigator

Marie G. Gantz, Co-Investigator

University of Pennsylvania

Lily Arya, Principal Investigator

Ariana Smith, Co-Investigator

Heidi Harve, Co-Investigator

Uduak Umoh Andy, Co-Investigator

Pamela Levin, Co-Investigator

Diane K. Newman, Co-Investigator

Mary Wang, Interventionist

Donna Thompson, Interventionist

Teresa Carney, Interventionist

Michelle Kingslee, Research Coordinator

Lorraine Flick, Research Nurse

University of Pittsburgh

Halina Zyczynski, Principle Investigator

Pam Moalli, Co-Investigator

Gary Sutkin, Co-Investigator

Jonathan Shepherd, Co-Investigator

Michael Bonidie, Co-Investigator

Steven Abo, Co-Investigator

Janet Harrison, Co-Investigator

Lori Geraci, Research Coordinator

Judy Gruss, Research Coordinator

Karen Mislanovich, Research Coordinator

Ellen Eline, Interventionist

Beth Klump, Interventionist

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sung, V.W., Borello-France, D., Dunivan, G. et al. Methods for a multicenter randomized trial for mixed urinary incontinence: rationale and patient-centeredness of the ESTEEM trial. Int Urogynecol J 27, 1479–1490 (2016). https://doi.org/10.1007/s00192-016-3031-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-016-3031-7

Keywords

Navigation